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The majority of people diagnosed with diabetes mellitus are in the working age group in developing countries. The inter-
relationship of diabetes and work, that is, diabetes affecting work and work affecting diabetes, becomes an important issue for 
these people. Therapeutic options for the diabetic worker have been developed, and currently include various insulins, insulin 
sensitizers and secretagogues, incretin mimetics and enhancers, and alpha glucosidase inhibitors. Hypoglycemia and hypoglycae-
mic unawareness are important and unwanted treatment side effects. The risk they pose with respect to cognitive impairment can 
have safety implications. The understanding of the therapeutic options in the management of diabetic workers, blood glucose 
awareness training, and self-monitoring blood glucose will help to mitigate this risk. Employment decisions must also take into 
account the extent to which the jobs performed by the worker are safety sensitive. A risk assessment matrix, based on the extent 
to which a job is considered safety sensitive and based on the severity of the hypoglycaemia, may assist in determining one’s fi t-
ness to work. Support at the workplace, such as a provision of healthy food options and arrangements for affected workers will 
be helpful for such workers. Arrangements include permission to carry and consume emergency sugar, fl exible meal times, self-
monitoring blood glucose when required, storage/disposal facilities for medicine such as insulin and needles, time off for medical 
appointments, and structured self-help programs.
Key Words: Blood glucose awareness training (BGAT), Fitness to work, Hypoglycemic unawareness, Safety sensitive, Self-monitor-
ing blood glucose
Introduction
Diabetes mellitus (DM) is now a major global health threat [1]. 
Worldwide numbers of affected people are expected to increase 
from an estimated 235 million in 2010 to 435 million in the 
year 2030 [2]. Statistics such as these have prompted the World 
Economic Forum to rank chronic diseases, of which diabetes 
is unarguably dominant, among three major risk areas in order 
to discuss the diseases in its Global Risks Network Report [3]. 
The growing burden of the disease is more acute in developing 
countries because of  the higher prevalence of  diabetes in the 
working age group of 40 to 60 years, compared to developed 
countries, where the majority with the disease is above 60 years 
of age [2].
Diabetes Mellitus Affecting Work
The multidimensional nature of  diabetes is well known. A 
holistic approach for its management is necessary [4] to reduce 
both microvascular and macrovascular complications [5,6]. 
Time and effort is required for adherence to a treatment regime 
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that requires scheduled screening for retinopathy, foot, renal, 
and cardiovascular risk factors [7]. Most of these factors take 
time to develop, and its impact on work is probably not imme-
diate, allowing time for affected workers, their supervisors, and 
physicians to adjust to changing circumstances.
A major immediate concern in the management of work-
ers with diabetes is the impact of hypoglycemia, quite often an 
iatrogenic effect of diabetes management. This condition is not 
rare (Table 1). In one study, 101 of 518 type1 diabetics above 
16 years of  age with diabetes durations exceeding two years 
had hypoglycemic unawareness in the preceding year [9]. In 
another study, twelve out of 122 insulin type2 diabetics using 
two or more insulin injections a day were noted to have hypo-
glycemic unawareness in the preceding year [10].
Hypoglycemia - A Safety Risk
Glucose is the obligate fuel for the brain. Glucose deprivation 
will result in cognitive impairment. When the blood sugar falls 
below 4 mmol/l, the response of  the normal human body is 
to stop all endogenous insulin secretion. Protective behavioral 
responses, such as feeding, commence, together with the stimu-
lation of glucagon. This response may, however, be inadequate 
in a diabetic patient.
The neurogenic and neuroglycopenic effects elicited 
through sympathetic arousal, such as perspiration, palpitations, 
hunger, giddiness, and tremors are often familiar to diabetic pa-
tients. This response is mediated by catecholamines. The level 
of  distress caused by such effects is not often appreciated by 
others, even by doctors. Secretion of cortisol and growth hor-
mones form the latter stages of the hypoglycemic response [11].
Hypoglycaemic Unawareness
The ultimate fear and threat to safety in relation to hypoglyce-
mia is the phenomena of  hypoglycemic unawareness. Inade-
quate responses to antecedent repeated exposures to hypoglyce-
mia can result in an altered lowered threshold to the activation 
and perception of hypoglycemia arousal.
Thus, such a diabetic worker may have lowered blood sug-
ar levels, posing an increasing fuel deprivation risk to the brain 
without his realizing it. His window for corrective intervention 
becomes progressively narrower and narrower till he plunges 
directly into a state of severe cognitive impairment. Sometimes, 
a co-worker may be the best person to have observed this actu-
ally happening, as for example, noticing a diabetic colleague 
behaving in an uncharacteristic manner. Fortunately, for most 
diabetics who have had hypoglycemic unawareness, the condi-
tion can be reversed [12]. 
The impact of hypoglycemia on cognitive functioning will 
also depend on the complexity of the task at hand [13]. In an 
environment that demands multiple foci of attention and judg-
ment, e.g., the cockpit of an airplane, or the intensive care unit 
in a hospital, this impact becomes critical. 
Studies have also shown that following a hypoglycemic 
episode of 3.1 mmol/L, reaction times do not return to normal 
until 20 to 30 minutes after euglycemia has been restored [14]. 
Subsequent experimental data in type 1 DM patients also sug-
gests that some aspects of cognitive function remain impaired 
for a clinically significant time after the correction of hypogly-
cemia [15].
Hypoglycemia and Safety Sensitive Jobs
Safety-sensitive jobs are ones where impaired performance, for 
whatever reason, could result in significant risks of harm to the 
health or safety of the worker. In addition, this risk may also 
affect the environment and the health or safety of co-workers 
[16]. To this, some legal authorities have further qualified that 
it must be also be a job performed with little or no supervision 
[17]. 
The concept of safety sensitive jobs is often traced to the 
implementation of  drug and alcohol testing policies at the 
workplace. However, the classification of jobs as safety sensitive 
for this purpose is mainly for identifying who in the workplace 
should be included for drug and alcohol screening, in a just and 
fair manner. The actions that follow upon the identification of 
a positive test are driven by standard operational procedures. 
Table 1. Prevalence of hypoglycemia and type 1 and type 2 DM patients
Type 1 DM Type 2 DM
All hypoglycemia [8] 4,300/100 patient years 1,600/100 patient years
Severe hypoglycemia [8] 115/100 patient years 35/100 patient years
Hypoglycemic unawareness 19.5% of patients [9] 9.8% of patients [10] 
DM: diabetes mellitus.
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In the context of diabetes, the identification of safety sen-
sitive jobs and whether a diabetic worker should be allowed to 
work these jobs should be part of a much wider picture of risk 
assessment. 
Arising from a fear of  what can happen, people with 
diabetes, especially type1 DM, are usually barred from certain 
jobs, such as pilots, as a matter of policy (Table 2). In a way, it 
is the collective judgment of society being applied to a small se-
lect group of occupations, deemed to be complex and demand-
ing of a state of high alertness. A number of these guidelines 
have international acceptance.
In many countries, there are also regulations that specify 
restrictions on the driving of  heavy goods vehicles, buses, or 
public transport vehicles, such as taxis, by insulin-treated pa-
tients.
Some inroads have been made to lift the restrictions for 
insulin-treated diabetics applying or continuing to be in em-
ployment in such jobs. These restrictions are almost universally 
qualified by fulfillment of strict documented conditions. These 
include stipulations that the diabetic worker has no episodes of 
severe hypoglycemia (defined as requiring assistance of another 
individual) in the preceding 1 year, and with no more than one 
episode of severe hypoglycemia in the preceding 5 years. Other 
requirements may include mandatory self-glucose monitoring 
with a meter that has a memory chip, and a signed statement 
testifying to satisfactory management by a diabetologist [18].
Fitness for Other Jobs
The fear of hypoglycemia, especially with insulin use, may also 
trigger reluctance for employers and doctors alike to recom-
mend people as fit for jobs outside the select group of occupa-
tions that are governed by established regulations. 
Such jobs and safety sensitive situations can be liberally 
Table 2. Insulin treatment and examples of restrictions for 
certain types of employment
Commercial pilots (ICAO guidelines) [18]
Occupational divers (Norwegian Board of Health) [19]
Group 2 licensees Drivers of large lorries, buses, taxis (DVLA) [20]
Firemen (NFPA) [21]
ICAO: International Civil Aviation Organization, DVLA: Driver and 
Vehicle Licensing Agency, UK, NFPA: National Fire Protection Asso-
ciation, US.
Table 3. Risk assessment and decision matrix for employment of diabetics with hypoglcyemia
American diabetic association classification of hypoglycemia [22]
Relative hypoglycemia Documented symptomatic 
hypoglycemia (with docu-
mented blood glucose <= 
3.9 mmol/L) 
Probable symptomatic hy-
poglycemia without blood 
glucose determination
Severe hypoglycemia defined 
as requiring the assistance 
of others (with or without 
documented blood glucose 





others, life and 
property
Mild consequences, e.g., office envi-
ronment, presence of 
co-workers
Moderate e.g., assembly lines, hot-
work, crane operation, with 
co-worker
Moderate e.g., assembly lines, hot-
work, crane operation, 
without co-worker
Severe consequences. e.g., 
firearm handling
 Intensify medical intervention Continuous improvement.
 Intensify medical intervention Urgent action, discuss with employer, may need to enhance work operations, including increased supervision 
and surveillance.
 Intensify medical intervention Immediate action: discuss with employer, may need temporary removal from task and job until remedial ac-
tion has been taken and completed.
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contemplated - the helper working in a crowded hectic kitchen 
(slips and falls), the refinery operator who has to enter a con-
fined space and work at heights (danger to plant safety), the 
police on his regular beat (firearms handling), and many other 
jobs that entail exposure to chemicals, moving parts, and men-
tal stress. 
These concerns are real and should not be dismissed. A 
risk assessment and decision matrix, based on the extent to 
which a job is considered safety sensitive is suggested in Table 3. 
The aim is to rehabilitate the patient so that he can be helped to 
work safely in all these jobs. The interim decision on the fitness 
to work of a worker with hypoglycemia will be guided by its 
severity and his recovery, not only from the hypoglycemia, but 
also his recovery with respect to his hypoglycemia awareness 
and avoidance of future episodes.
Many jobs which ostensibly have safety sensitive implica-
tions, may, on closer scrutiny, turn out not to be this sensitive. 
A condominium guard who is not required to handle 
firearms and whose job is to alert for help in the event of emer-
gency is an example. The presence of co-workers can also be a 
mitigating factor. Many work operations are also highly auto-
mated. Alarms are set in place for safety protection. 
Balanced against this are factors that can worsen a hypo-
glycemic risk, e.g. sleep deprivation resulting in fatigue often 
seen in shift work may worsen hypoglycemic unawareness.
A decision based on fitness should be individualized, 
based on the person and the circumstances of his job.
Danger of Hypoglycemia 
Resulting from Treatment
Despite modern advances, the pharmacological mimicry of 
the normal physiological glycemic response is not perfect. All 
pharmacological agents, with their fixed mode and duration 
of action, are unable to achieve the kind of fine tuned glucose 
homeostasis seen in normal human physiology, which keep 
glucose levels within a narrow range. 
In the continuing efforts to overcome hyperglycemia, 
hypoglycemia will continue to be a common challenge in treat-
ment - especially as standards of care continue to drive patients 
to optimal A1C targets of 7% or even lower. 
The risk of hypoglycaemia from pharmacological modali-
ties to treat hyperglycemia varies, with insulin use carrying the 
highest risk compared to oral agents [23]. In a study of type 2 
patients randomized to various treatments for 6 years from the 
time of  diagnosis, the risk was estimated to vary from 5.3% 
for those on a basal and bolus insulin combination to 3.8% for 
those on a basal insulin monotherapy, to 1.2% for those on sul-
phonylurea [23].
Evidence for the benefits of  early and effective achieve-
ment of glycemic targets to avoid long term macrovascular and 
microvascular complications related to hyperglycemia frequent-
ly results from a combination of agents being used.
Understanding the Use and 
Effects of Diabetic Medication
The use of insulin cannot be avoided in many patients, besides 
those with type1 DM. Patients with type2 DM who are at the 
insulinopenic end of the disease spectrum will require the use 
of insulin. Indeed, of all the agents in the armamentarium for 
hyperglycemia, insulin remains the most potent, without a limit 
to its A1C lowering capability, unlike the other agents. 
The peak action of  insulin corresponds generally to the 
highest potential hypoglycemic risk. Understanding this and 
the duration of action of the different insulins and correlating 
these to lifestyle factors such as meal times and physical activ-
ity become crucial (Fig. 1). There is some variation between 
individuals in their response to the same medication. The peak 
of  administered insulin or insulin secretagogues action must 
coincide with the estimated glucose peak from food absorption. 
The rapid acting insulin analogues (insulin aspart, gluli-
sine, and lispro) have an onset of action within fifteen minutes 
and peak relatively early. For workers requiring bolus insulin, 
its use has the flexible advantage of allowing them to eat almost 
immediately following the injection.
Fig. 1. Activity profiles of different types of insulin. Reprinted with 
permission from diabetes education online, diabetes teaching center. 
NPH: neutral protamine hagedorn. 
Copyright © 2009 The Regents of the University of California, all 
rights reserved, www.deo.ucsf.edu.
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Choice of Insulins for the Working Patient
The choice of  insulins for the physician and the patient has 
widened considerably in recent years. Therefore, selecting the 
appropriate insulin to best suit an individual’s lifestyle and their 
occupational profile can and should be done.
Basal insulin analogues, being relatively peakless, may 
be administered as an insulin monotherapy. These include 
glargine, which has a duration of action lasting 24 hours [24]. 
Another option is detemir, which, depending on the dose, has a 
variable duration of action between 16 to 24 hours and a small 
weight gain effect [25,26]. Such insulin use may find favor with 
shift workers, who have erratic sleep/wake schedules and meal 
times.
However, its use alone may not be adequate for glycemic 
control, especially if  postprandial glucose levels remain high. 
Thus, its combination with short acting insulins, such as hu-
man regular insulin, or rapid acting insulin analogues, such as 
glulisine, aspart, and lispro, may be medically indicated.
In other instances, pre-mix insulins may also be adminis-
tered. Continuous subcutaneous insulin infusion is another mo-
dality favored by a select group of motivated patients. It may be 
necessary to seek the advice of a physician with the necessary 
experience in insulin use to help the worker achieve the twin 
goals of target A1C and safety at work.
Insulin Secretagogues 
Insulin secretagogues, such as the sulphonylureas, have been 
used for many years. As a class, the side effect of hypoglycemia 
is well known. Some of  the newer generation secretagogues, 
such as the metaglitinides, have been promoted based on their 
shorter durations of action, minimizing the risk of hypoglyce-
mia. 
Insulin Sensitizers
The risk of hypoglycemia in this class of agents, which includes 
metformin and the peroxisome proliferator activated receptor 
gamma (ppar-gamma) agonists, collectively known as thiazoli-
dinediones, is considered minimal when used as a monothera-
py [27].
Incretin Mimetic and Enhancer
The “incretin effect” is the difference in glucose-stimulated 
insulin secretion from an oral versus an intravenous glucose bo-
lus, mediated through intestinal peptide hormones - glucagon 
like peptide-1 and glucose-dependent insulinotropic polypep-
tide [28]. Recent years have seen the advent of incretin mimet-
ics, such as exenatide and liraglutide (in injections forms), and 
incretin enhancers, such as the gliptins, being used in the effort 
to intensify diabetes treatment. As their actions are glucose 
dependent, it is presumed that there is less or no hypoglycemic 
risk [27].
Alpha Glucosidase Inhibitors
This agent acts within the gut and impedes the action of  en-
zymes that break down carbohydrates in the gut. The hypogly-
cemic risk is also considered low [27].
How Should the Individual Diabetic 
Worker Be Assessed?
History
The causes, symptoms, and signs of any hypoglycemic episode 
should always be sought at each physician visit. A recount-
ing of an experience of disorientation and recovery without a 
recollection of what happened is a strong indication of hypo-
glycemic unawareness. The impact of this is potentially more 
profound than mild symptomatic hypoglycemia episodes that 
are rapidly and easily amenable to self-correction and which, 
for all intents and purposes, are less likely to result in harm. 
Workers with a high A1C while undergoing intensive 
treatment may also experience hypoglycemic symptoms at 
the treated and lowered, but non-hypoglycemic, blood glucose 
levels. This is relative hypoglycemia, which though uncomfort-
able, is a benign and self-limiting condition, easily relieved by 
some feeding.
The corresponding action at work of whether the affected 
person should be removed from the job (Table 3 - red cells), 
and for how long, or whether some urgent remedial measures 
should be applied (remaining in the job, but with additional 
measures, such as intensifying supervision) should then be 
planned.
State of Glycemic Control
The state of glycemic control has to be examined. It is intuitive 
to worry less about hypoglycemic risk if  the diabetic worker 
has glucose levels constantly in the poorly controlled hyper-
glycemic range, compared to one managed to optimal A1C 
targets. However, even then, one has to be alert to the vagaries 
of “averages”. An A1C of 8% or more could also be accounted 
for by wide swings in glycemic variation. 
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The planned action in all cases should include counseling 
and expert medical advice to prevent, minimize, and manage 
hypoglycemia.
Self-Monitoring of Blood Glucose (SMBG)
Diabetic workers should always be encouraged to perform 
SMBG. Perhaps more important than the timing of these read-
ings (e.g. fasting, post meal, pre-sleep, bedtime) is the ability of 
the worker concerned to weave a story around the particular 
reading, correlating it to the timing and nature of  meals, his 
level of physical exertion, his medication, and his mental state. 
Doctors requesting SMBG from patients must help the patient 
make a meaningful interpretation of his reading.
How frequent these readings should be taken will depend 
on the personal glycemic circumstances and the safety sensitive 
content of the work involved. For instance, a diabetic worker 
who has embarked on increased physical activity (either at 
work or at leisure) or a change in dietary habits will need more 
SMBG in the interim. Adjustment in treatment may be neces-
sary. Similarly, a driver embarking on a long driving trip will 
probably require SMBG to be done during his trip. The higher 
the implied extent of safety sensitivity in the job, the more read-
ily one should recommend SMBG.
Blood Glucose Awareness 
Training (BGAT) [29]
Psycho-educational intervention training programs, such as 
BGAT, have been proven to be effective in reducing unfavorable 
events, notably driving mishaps among patients with diabetes. 
It is reasonable to infer that structured programs such as this 
can be applied for workers in safety sensitive jobs as well. An 
important component of this program is training the diabetic 
person to recognize his internal cues and to correlate this to his 
blood glucose levels. 
Self-treatment
Self-treatment in hypoglycemic emergencies should be empha-
sized. When in doubt, stop whatever activity and treat. The 
recommendation is to check SMBG if  possible, and to con-
sume 15 gm of rapidly absorbable carbohydrates in the event 
of hypoglycemia. This is to be followed by a SMBG check after 
fifteen minutes to ensure that glucose levels are ascending and 
normalized. Additional carbohydrates or snacks may be needed 
if  the next meal is more than an hour away [30].
Sweets should always be kept within reach of  the dia-
betic worker for such emergencies. Trained colleagues can and 
should provide help spontaneously, especially if  the worker is 
experiencing difficulties.
Should the Diabetic Worker Inform 
His Co-worker or Supervisor?
Medical information is sensitive. The reluctance to share this 
with others at work is understandable. Balanced against this is 
the benefit of  receiving appropriate assistance from others in 
the event of  diabetic emergencies, especially during hypogly-
cemia. Workers should be encouraged to reflect on this and to 
share knowledge of  their medical condition with a close col-
league or supervisor. The use of a medic alert bracelet or tag 
should be also considered.
The diabetic worker who refuses to cooperate with medi-
cal advice and whose hypoglycemic risk poses a threat at his 
workplace is hopefully a rarity. However, should such a situa-
tion arise, the public interest argument of breaching confiden-
tiality and informing the relevant authorities at the workplace 
may supersede the privilege of medical confidentiality.
Case 1
Mr. X is a type2 DM, and he works as a handler for a courier 
service company. A bolus insulin has been added to his treat-
ment pre-lunch in order to optimize control. His work duty is 
a mix of office work and operations work on fixed days of the 
week. On the operations days, he is required to lift and load up 
packages in the afternoons. He gives a history of discomfort - 
which he thinks is due to hypoglycemia on the afternoons of 
his operations days. In particular, he is able to recount a history 
of  perspiration occurring around the lips, which is different 
from whole body perspiration due to heat. 
The hypoglycemia can be easily confirmed by SMBG. 
Downward adjustment of his pre-lunch insulin would be one 
option. Rapid acting insulin analogues may be preferred over 
regular human short acting insulin. Another alternative, which 
may not be favored as a long-term solution, especially if  weight 
gain is an issue, is to have a snack to relieve the hypoglycemia. 
The likelihood of severe potential consequences is moderate, 
but overall, there is probably no need to recommend an imme-
diate removal from work duties.
Case 2
Mr. Y is a 29-year-old type1 DM on multiple doses of insulin a 
day. He has been trained and employed as a croupier in a casi-
no for the past three years. He is well respected among his peers 
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and management for his numeracy talent. There has been no 
problem with his work until recently for the past three months 
when he changed his diet, and started to reduce his intake of 
carbohydrates. There were two clinical episodes while at work, 
one when he experienced blurring of vision and another when 
he nearly ‘blanked out’ and had to be helped by a colleague to 
the medical center to seek treatment. His blood glucose level 
was 1.5 mmol/L. 
Acute measures to correct this will have to be taken. 
Given the history, it must be assumed that Mr. Y has hypo-
glycemic unawareness. Allowing the glucose levels to rise and 
scrupulously avoiding further exposure to hypoglycemia can re-
store awareness by two to three weeks [12]. Obviously this time 
frame is one important consideration in the assessment of any 
return to work fitness assessment. The physician will also have 
to be guided by frequent blood glucose monitoring. A continu-
ous glucose monitoring system is one useful tool in such cases. 
This makes use of a sensor inserted beneath the skin that cap-
tures blood glucose trend data, up to 288 readings over a 24-
hour period, without the need for intermittent finger pricking 
for SMBG.
Medical advice would include carbohydrate counting as 
well as insulin adjustments to match carbohydrate intake. Med-
ical and occupational health input is, of course, crucial to the 
company’s employment decision with respect to the worker.
Work Affecting Diabetes: 
Support at the Workplace
Diabetic workers in the community are becoming increasingly 
common. A restrictive policy on employment may not be re-
alistic or tenable. Losing in the competition for talent is one 
thing, but being labeled as biased is another. Whilst efforts at 
prevention must continue, society and employers must also be 
proactive in their support for such workers. 
Very often, such support need not be elaborate. A provi-
sion of  healthy food options at workplace canteens, flexible 
meal times, and arrangements for affected workers (permission 
to carry and consume emergency sweets or sugary drinks) are 
some such supports. Permission and privacy for SMBG when 
required is also a way employers can help such employees. The 
employer can also assist with facilities for storage of medica-
tions, such as insulin, and for safe disposal of used needles and 
other consumables. Management support for medical appoint-
ments and structured programs that improve self-help and edu-
cation in diabetic care is also important. 
Supportive employers are also less likely to have to deal 
with issues of concealment and unexpected consequences.
 
Take Home Messages
• Workers with diabetes, especially when on treatment with 
insulins and/or insulin secretagogues are at risk for hypogly-
cemia. This can affect cognitive function.
• Hypoglycemic unawareness can have dangerous consequenc-
es. This risk can be prevented and be reversed, if  already pres-
ent. 
• Causes should be identified and measures taken to mitigate 
the risk of hypoglycaemia. 
• Physicians with responsibility for diabetic workers should be 
alert to this risk. Risk assessment for fitness to work should be 
performed. 
• Support from employers to the needs of the diabetic worker is 
crucial in terms of management of his condition.
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